Roquefort Thera (ROQ) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 48,915 | 0.975p | Ordinary |
14:48:38 - 26-Mar-26 |
| Buy* | 200,000 | 0.975p | Ordinary |
13:55:15 - 26-Mar-26 |
| Sell* | 18,259 | 0.9975p | Ordinary |
13:07:28 - 26-Mar-26 |
| Unknown* | 200,000 | 1.00p | Ordinary |
12:12:45 - 26-Mar-26 |
| Sell* | 23 | 0.955p | Ordinary |
09:00:24 - 26-Mar-26 |
| Sell* | 3,462 | 0.95p | Ordinary |
15:23:30 - 25-Mar-26 |
| Sell* | 250,000 | 0.955p | Ordinary |
14:38:21 - 25-Mar-26 |
| Sell* | 100,000 | 0.95p | Uncrossing Trade |
16:40:34 - 24-Mar-26 |
| Unknown* | 0 | 0.95p | SI Trade |
09:20:32 - 23-Mar-26 |
| Buy* | 89 | 1.10p | SI Trade |
09:20:32 - 23-Mar-26 |
Roquefort Thera (ROQ) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Mar 2026 1:00 pm | RNS-R | Investor Presentation |
| 26th Mar 2026 12:08 pm | RNS | Result of General Meeting |
| 25th Mar 2026 7:00 am | RNS | Lyramid SPA & MK Cell License Update |
| 2nd Mar 2026 8:00 am | RNS | Schedule One - Roquefort Therapeutics PLC |
| 2nd Mar 2026 7:00 am | RNS | Proposed Acquisition and Fundraise of £8.5 million |
| 25th Feb 2026 7:00 am | RNS | Transaction Update & Notice of Intention to Delist |
| 15th Jan 2026 7:00 am | RNS-R | Research Note Published |
| 12th Dec 2025 7:00 am | RNS | Clinical Trial & License Agreement Update |
| 9th Dec 2025 7:00 am | RNS | Conversion of CLNs |
| 1st Dec 2025 10:35 am | RNS | Ex-Entitlement Date - Unlisted RNV Shares |